Glympse Bio, Inc, based in Cambridge, is at the forefront of developing a groundbreaking platform that enables the measurement of protease activity using a simple blood draw.
Their innovative technology allows for the accurate diagnosis and monitoring of various diseases, revolutionizing the way healthcare professionals approach patient care.
Generated from their website's infomation